Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds.

The successful incorporation and sustained release of a hydrophilic antibiotic drug (Mefoxin, cefoxitin sodium) from electrospun poly(lactide-co-glycolide) (PLGA)-based nanofibrous scaffolds without the loss of structure and bioactivity was demonstrated. The morphology and density of the electrospun scaffold was found to be dependent on the drug concentration, which could be attributed to the effect of ionic salt on the electrospinning process. The drug release behavior from the electrospun scaffolds and its antimicrobial effects on Staphylococcus aureus cultures were also investigated. In all tested scaffolds, the maximum dosage of drug was released after 1 h of incubation in water at 37 degrees C. The usage of the amphiphilic block copolymer (PEG-b-PLA) reduced the cumulative amount of the released drug at earlier time points and prolonged the drug release rate at longer times (up to a 1-week period). The antibiotic drug released from these electrospun scaffolds was effective in their ability to inhibit Staphylococcus aureus growth (>90%). The combination of mechanical barriers based on non-woven nanofibrous biodegradable scaffolds and their capability for local delivery of antibiotics increases their desired utility in biomedical applications, particularly in the prevention of post-surgical adhesions and infections.

[1]  K. Rodgers,et al.  Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion-prevention model. , 1995, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[2]  Thomas Zimmerman,et al.  Prevention of Postsurgery-Induced Abdominal Adhesions by Electrospun Bioabsorbable Nanofibrous Poly(lactide-co-glycolide)-Based Membranes , 2004, Annals of surgery.

[3]  Darrell H. Reneker,et al.  Beaded nanofibers formed during electrospinning , 1999 .

[4]  F. Lowy.  Staphylococcus aureus infections. , 2009, The New England journal of medicine.

[5]  Kristi S. Anseth,et al.  Predicting Controlled-Release Behavior of Degradable PLA-b-PEG-b-PLA Hydrogels , 2001 .

[6]  I. Chin,et al.  Crystallization behavior of biodegradable amphiphilic poly(ethylene glycol)-poly(L-lactide) block copolymers † , 1999 .

[7]  D Eisenberg,et al.  Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. , 1997, Science.

[8]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[9]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[10]  Darrell H. Reneker,et al.  Electrospinning process and applications of electrospun fibers , 1995 .

[11]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[12]  B. Shirley,et al.  Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[13]  P. Cristoforoni,et al.  Endogenous versus exogenous IL-10 in postoperative intraperitoneal adhesion formation in a murine model. , 1997, The Journal of surgical research.

[14]  R. Bronson,et al.  Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions. , 1995, The Journal of surgical research.

[15]  M. Brenner,et al.  Experimental characterization of electrospinning: the electrically forced jet and instabilities , 2001 .

[16]  B. Hsiao,et al.  Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Joel Rosenblatt,et al.  Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[18]  P. Campbell,et al.  Evaluation of a sprayable polyethylene glycol adhesion barrier in a porcine efficacy model. , 2001, Human reproduction.

[19]  D. Menzies.  Peritoneal adhesions. Incidence, cause, and prevention. , 1992, Surgery annual.

[20]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[21]  M. Diamond,et al.  Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. , 1996, Fertility and sterility.

[22]  K. Sekiba.  Use of Interceed(TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. , 1992, Obstetrics and Gynecology.

[23]  Kwangsok Kim,et al.  Structure and process relationship of electrospun bioabsorbable nanofiber membranes , 2002 .

[24]  Stephen E. Harding,et al.  Polylactide−Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming Systems , 1996 .